Allele Name
Irf2, targeted mutation 1
T cell-interacting, activating receptor on myeloid cells 1, Yoichiro Iwakura, University of Tokyo
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked; endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
Sall1, targeted mutation 1
targeted mutation 1, Chugai Pharmaceutical Co., Ltd.
Dnaja1, targeted mutation 1
Pdlim2, insertion mutation
PymrR2, 129 allele
transgene 2
transgene 10, Institute of molecular embryology and genetics
Par2, C57BL/6 allele
transgene 24, Institute of molecular embryology and genetics
targeted mutation 81, Institute of molecular embryology and genetics
cold inducible RNA binding protein, targeted mutation 1
transgene insertion 5-23
targeted mutation 1, Anthony Wynshaw-Boris
minichromosome maintenance deficient 3 (S. cerevisiae) associated protein, targeted mutation 1
transgene insertion 01, Research Institute for Microbial Diseases, Osaka University
Activin receptor type 1; targeted mutation 1
DNA-damage inducible transcript 3; targeted mutation 1, Shizuo Akira
Wnt3a, vestigial
targeted mutation 1; Sakuhei Fujiwara
transgene insertion 5, Kiyoshi Kawakami
centrin 1, endonuclease-mediated mutation 6, Research Institute for Microbial Diseases, Osaka University
forkhead box N1
targeted mutation 1, knock-in (EGFP)
transgene insertion 26, Yoshiaki Nakajima
capping protein (actin filament) muscle Z-line, alpha 3; targeted mutation 1, Hirohide Takebayashi, Keisuke Watanabe
transgene insertion 273M2, Keiko Abe
sine oculis-related homeobox 5 homolog (Drosophila)/targeted mutation 1, Steve Tapscott
transgene insertion 304, Izumi Nakashima, Nagoya University School of Medicine
transgene insertion 90 Jun-ichi Miyazaki
transgene insertion 041 Hamamatsu University School of Medicine
transgene insertion 03, Research Institute for Microbial Diseases, Osaka University
VPS52 GARP complex subunit, targeted mutation 2.1,
heparin-binding EGF-like growth factor, targeted mutation 1
membrane-spanning 4-domains, subfamily A, member 13, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion, Ian Jackson, Western General Hospital
a disintegrin and metallopeptidase domain 3 (cyritestin), targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
radial spoke head 6 homolog A (Chlamydomonas); endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
Protein Kinase D2, targeted mutation 1, Akihiro Harada
Fez family zinc finger 1, targeted mutation 1
recombination activating gene 2, targeted mutation 1
BC089491, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
DNA-damage inducible transcript 3, targeted mutation 1,
recombination activating gene 2, targeted mutation 1,
RIKEN cDNA 4930522H14 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
leukocyte receptor cluster (LRC) member 8, targeted mutation 1,
potassium inwardly-rectifying channel, subfamily J, member 6, targeted mutation 1,
Pyruvate kinase, muscle , endonuclease-mediated mutation 1,
myeloblastosis oncogene, targeted mutation 3,
WBP2 N-terminal like, targeted mutation 1b, Research Institute for Microbial Diseases,Osaka University
synaptogyrin 4, targeted mutation 1, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
minichromosome maintenance complex component 3 associated protein, targeted mutation 1,Department of Immunology, Kumamoto University Medical School
calreticulin3, targeted mutation 1, Research Institute for Microbial Diseases,Osaka University
hepatocyte cell adhesion molecule 2, targeted mutation 1,
C2 calcium-dependent domain containing 4C, targeted mutation 1,
testis expressed gene 22, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
leucine rich repeat containing 36, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
Pmis2, sperm specific protein; targeted mutation 1, Masaru Okabe
3-hydroxy-3-methylglutaryl-Coenzyme A reductase; targeted mutation 1, Shun Ishibashi
sine oculis-related homeobox 4, endonuclease-induced mutation 2
protein kinase, DNA activated, catalytic polypeptide; severe combined immunodeficiency
sal-like 1 (Drosophila), targeted mutation 1, Ryuichi Nishinakamura
progestin and adipoQ receptor family member VI, targeted mutation 1, Ikuo Kimura, Kyoto University
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human), targeted mutation 2
serine protease inhibitory Kazal type 3, targeted mutation 1
D9Mit279, 129 allele
Cd9, targeted mutation 1
Zrf2, insertion mutation
D9Mit277, 129 allele
Tom34, targeted mutation 1, Institute of Molecular Embryology and Genetics, Kumamoto University
Dnaja2, targeted mutation 2
Hpca, targeted mutation 1, School of Pharmaceutical Sciences, Toho University
Bcl6, targeted mutation 1
Adra1d, targeted mutation 1
targeted mutation 1, Institute of Molecular Embryology and Genetics
xeroderma pigmentosum, complementation group A, targeted mutation 1
targeted mutation 1, Masashi Yanagisawa
transgenic insertion 304, Izumi Nakashima, Nagoya University Graduate School of Medicine
cadherin2, targeted mutation 2, Ayae Kinoshita, Kyoto University
ATPase inhibitory factor 1, targeted mutation 1, Masasuke Yoshida, Kyoto Sangyo University
B-cell CLL/lymphoma 9-like; targeted mutation 1, Tetsu Akiyama
Basonuclin 2; targeted mutation 1, Center for Animal Resources & Development
transgene insertion M1, Keiko Abe
l(3)mbt-like 3 (Drosophila), targeted mutation 1, Toru Miyazaki, the University of Tokyo
sine oculis-related homeobox 4 homolog (Drosophila); targeted mutation 1(LacZ); Kiyoshi Kawakami
Free fatty acid receptor 1, targeted mutation 1
S-phase kinase-associated protein 1A, targeted mutation 1,
a disintegrin and metallopeptidase domain 3 , targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion P2, Nobuaki Tamamaki
Free fatty acid receptor 2, targeted mutation 2
ring finger protein 43, targeted mutation 1,
Gt(pU-21B)210Imeg, targeted mutation 1, Naomi Nakagata Center for Animal Resources & Development
hydroxycarboxylic acid receptor 2 , targeted mutation 1
vacuolar protein sorting 13A; targeted mutation 1, Akira Sano
transgene insertion 2, Research Institute for Microbial Diseases, Osaka University
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, targeted mutation 1,
BC051628, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
RIKEN cDNA 4931406B18 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
HNF1 homeobox B , targeted mutation 1,
secreted frizzled-related protein 2, targeted mutation 1,
Transgene insertion
Farnesyl diphosphate farnesyl transferase 1, targeted mutation 1,
a disintegrin and metallopeptidase domain 18, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
PCI domain containing 2; targeted mutation 1, Nobuo Sakaguchi
calpain 11, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
gametocyte specific factor 1-like, targeted mutation 1,
a disintegrin and metallopeptidase domain 18, targeted mutation 2, Research Institute for Microbial Diseases, Osaka University
tripartite motif family-like 1, targeted mutation 1,
neurogenic differentiation 6, targeted mutation 1,
Neutral cholesterol ester hydrolase 1 , targeted mutation 1, Shun Ishibashi, Jichi Medical University
microRNA 200b, targeted mutation 1.1, Research Institute for Microbial Diseases, Osaka University
prostaglandin E receptor 2 (subtype EP2), targeted mutation 1,
thromboxane A2 receptor, targeted mutation 1, Shuh Narumiya, Kyoto University
prostaglandin I receptor,targeted mutation1, Shuh Narumiya, Kyoto University
Parp1,National Cancer Center Research Institute
pancreas transcription factor 1a, targeted mutation 1
Parg,National Cancer Center Research Institute
transgene insertion RBGS002, Research Institute for Microbial Diseases, Osaka University
Il2rg, targeted mutation 1
Runx 1, targeted mutation 1
D9Mit212, 129 allele
Rho, targeted mutation 1
Dtr, targeted mutation 2
D9Mit78, 129 allele
Cplx2, targeted mutation 1
Atp6v0c, targeted mutation 1
targeted mutation l.2, Nils-Goran Larsson, Karolinska Hospital
sal-like 3 (Drosophila), targeted mutation 1
targeted mutation 4, Institute of Molecular Embryology and Genetics
placental specific protein 1, targeted mutation 1, Research Institute for Microbial Diseases,Osaka University
transgene insertion REP08, Research Institute for Microbial Diseases, Osaka University
Synd4, targeted mutation 1
transgene insertion M4, Keiko Abe
interleukin 1 receptor antagonist; targeted mutation 3, Yoichiro Iwakura, University of Tokyo
transgene insertion
DnaJ (Hsp40) homolog, subfamily A, member 2; targeted mutation 4, Naomi Nakagata
DnaJ (Hsp40) homolog, subfamily A, member 2; targeted mutation 3, Naomi Nakagata
Cholecystokinin A receptor; targeted mutation 1, Soichi Takiguchi
ATPase, Na+/K+ transporting, alpha 3 polypeptide; targeted mutation, Kiyoshi Kawakami
targeted mutation 1, Masashi Katoh, Nagoya University, School of Medicine
oocyte expressed protein homolog; targeted mutation 1, Jun-ichi Miyazaki
targeted mutation 1, The Institute of Physical and Chemical Research (RIKEN)
transgene insertion, Jun-ichi MIyazaki
Nidd5, BALB/c allele
calmegin, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion C3-N01-FJ002, Research Institute for Microbial Diseases, Osaka University
progestin and adipoQ receptor family member VI, targeted mutation 1
apolipoprotein E, targeted mutation 1,
small integral membrane protein 23, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
serine peptidase inhibitor, Kazal type 8, endonuclease-mediated mutation 1,2, Research Institute for Microbial Diseases, Osaka University
sperm acrosome associated 7, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
fragile X mental retardation 1 neighbor, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
sperm tail PG rich repeat containing 4, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
ubiquilin 3, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transmembrane and coiled-coil domains 5, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
predicted gene 5617, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
hepatic nuclear factor 4, alpha, targeted mutation 1,
Tnnt2, targeted mutation 1
izumo sperm-egg fusion 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transmembrane protein 247, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
spermatogenesis associated 16, endonuclease-mediated mutation 1,2, Research Institute for Microbial Diseases, Osaka University
Rab8b, member RAS oncogene, targeted mutation 1
solute carrier family 18 (vesicular monoamine), member 2, targeted mutation 2a,
calnexin; targeted mutation 1.1, Research Institute for Microbial Diseases, Osaka University
Protein kinase D2, targeted mutation 1
death effector domain-containing DNA binding protein 2, targeted mutation 1, Toru Miyazaki
gene trap Ayu21-84, Institute of molecular embryology and genetics
targeted mutation 2, Institute of Molecular Embryology and Genetics
Nbn, targeted mutation 1
targeted mutation 128, Institute of molecular embryology and genetics
signal-induced proliferation-associated 1 like 1; gene trap, Institute of Molecular Embryology and Genetics
Dnaja1, targeted mutation 2
SMAD family member 7; gene trap, Institute of Molecular Embryology and Genetics
Sall2, targeted mutation 1
PymrR3A, 129 allele
D9Mit273, 129 allele
Dtr, targeted mutation 1
D9Mit289, 129 allele
Pymr2A, 129 allele
transgene insertion CZ-M02, Research Institute for Microbial Diseases, Osaka University
transgene insertion
gene trap Ayu21-138, Institute of molecular embryology and genetics
transgene insertion 1, Taeko Miyagi
targeted mutation 1, Taeko Miyagi
transgene 18, Institute of molecular embryology and genetics
targeted mutation 1, Naomi Nakagata
targeted mutation 1, Masashi Yanagisawa, Howard Hughes Medical Institute
cadherin 2, targeted mutation 1, Ayae Kinoshita, Kyoto University
hepatic nuclear factor 4, alpha, targeted mutation 1, Naomi Nakagata
glycerol kinase 2, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion, Sunnybrook & Women's College HSC
Basonuclin 2; targeted mutation 1, Center for Animal Resources and Development
serine/arginine-rich splicing factor 4; gene trap, Institute of Molecular Embryology and Genetics
DnaJ (Hsp40) homolog, subfamily B, member 1; targeted mutation 1, Naomi Nakagata
Odd-skipped related 1, targeted mutation 1 (knockin)
Free fatty acid receptor 3, targeted mutation 1
pancreatic and duodenal homeobox 1, targeted mutation 1, Naomi Nakagata
transgene insertion 12, Nobuo Sakaguchi
RAB8A, member RAS oncogene family, targeted mutation 1
calreticulin, targeted mutation 1.1, Research Institute for Microbial Diseases, Osaka University
uridine phosphorylase 1, targeted mutation 3,
transgene, National Cancer Center Research Institute
testis specific gene A13, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
WD repeat domain 63, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
coiled-coil domain containing 63, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
membrane-associated ring finger (C3HC4) 11, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
RIKEN cDNA 1110017D15 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
colony stimulating factor 1 receptor, endonuclease-mediated mutation 1,
phospholipase A2 inhibitor and LY6/PLAUR domain containing, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
family with sequence similarity 217, member A, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
Fez family zinc finger 2, targeted mutation 1
GS homeobox 2, targeted mutation 1,
polymerase (DNA directed), iota, Targeted mutation 1, Gang-Hong Lee
hyaluronan and proteoglycan link protein 2; targeted mutation 1
pancreatic and duodenal homeobox 1, targeted mutation 1,
phospholipase C, zeta 1, endonuclease-mediated mutation 3, Research Institute for Microbial Diseases, Osaka University
spermatogenesis associated 16, endonuclease-mediated mutation 2, Research Institute for Microbial Diseases, Osaka University
IZUMO1 receptor, JUNO, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
phospholipase C, zeta 1 , endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
ubiquilin-like, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
lipase,hormone sensitive, targeted mutation 1, Shun Ishibashi, Jichi Medical University
acetyl-Coenzyme A acetyltransferase 1, targeted mutation 1, Shun Ishibashi, Jichi Medical University
scavenger receptor class F, member 1, targeted mutation 1, Shun Ishibashi, Jichi Medical University
Rab8a, member RAS oncogene, targeted mutation 1
Sorbitol dehydrogenase, endonuclease-mediated mutation 1,
lysozyme-like 6, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
dynein, axonemal, intermediate chain 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
death effector domain-containing, targeted mutation 1, Toru Miyazaki
carboxylesterase 1F, targeted mutation 1,
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked, endonuclease-mediated mutation 2, Research Institute for Microbial Diseases, Osaka University
glucagon; targeted mutation 1, Yoshitaka Hayashi
4-hydroxyphenylpyruvic acid dioxygenase, hypertyrodinemia; Central Inst. for Experimental Animals
T-box 1; targeted mutation 1, Virginia Papaioannou
targeted mutation 1
Prkr, targeted mutation 1
targeted mutation 1, Center for Animal Resources and Development, Kumamoto University
non imprinted in Prader-Willi/Angelman syndrome 1 homolog (human), targeted mutation 1
targeted mutation 2
transgene insertion, Karl X. , Department of Molecular Biology and Microbiology, and Biomolecular Science Center, University of Central Florida
Gpr30, targeted mutation 1
targeted mutation 1, Division of Cellular and Molecular Medicine, Kobe University School of Medicine
Hprt, targetedd mutation 1
targeted mutation 1, Shinichi Uchida
Cd9, targeted mutation 1, Research Institute for Microbiological Diseases, Osaka University
H2, NZW allele
Isgf3g, targeted mutation 1
Pymr, 129 allele
prostaglandin E receptor 4, targeted mutation 1, Shu Narumiya, Kyoto University
Fos, targeted mutation 1
Ifng, targeted mutation 1
Ttr, targeted mutation 1
Pmaip1, targeted mutation 1
transgene insertion 3
prostaglandin E receptor 1, targeted mutation 1, Shuh Natumiya, Kyoto University
dynein, axonemal, heavy chain 11; situs inversus viscerum
targetd mutaion 1.2, Nils-Goran Larsson, Karolinska Hospital
Janus kinase 3; targeted mutation 1, RIKEN
myeloid/lymphoid or mixed-lineage leukemia 1; targeted mutation 1.1, Michael L Cleary
targeted mutation 1, Naomi Nakagata Center for Animal Resources and Development, Kumamoto University
transgene insertion CX,
Sall4tm1180Imeg
transgene insertion 5, Hiroko Oshima
serine peptidase inhibitor, Kazal type 3; targeted mutation 1, Institute of Molecular Embryology and Genetics
growth hormone, targeted mutation 1,
ATPase, Na+/K+ transporting, alpha 2 polypeptide; targeted mutation 1, Kiyoshi Kawakami
transgene insertion A12, Ian Jackson, Western General Hospital
RIKEN cDNA B230118H07 gene, targeted mutation 1,
RIKEN cDNA B230118H07 gene, targeted mutation 2,
structural maintenance of chromosomes 1B, Hamamatsu University School of Medicine
calreticulin, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
targeted mutation, Institute of Molecular Embryology and Genetics
neurogenic differentiation 1, targeted mutation 1, Naomi Nakagata, Center for Animal Resources & Development
transgene insertion 7, Nobuo Sakaguchi
targeted mutation 1, Center for Animal Resources & Development
D2Mit157, BALB/c allele
thymidine phosphorylase, targeted mutation 3,
transgene insertion, Research Institute for Microbial Diseases, Osaka University
WBP2 N-terminal like, targeted mutation 1b, Research Institute for Microbial Diseases, Osaka University
vacuolar protein sorting 13A, targeted mutation 1, Akira Sano
protein phosphatase 3, catalytic subunit, gamma isoform, targeted mutation 1, Research Institute for Microbial Diseases,Osaka University
calcium-binding tyrosine-(Y)-phosphorylation regulated (fibrousheathin 2), endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
lysozyme-like 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
Protein Kinase D1, targeted mutation 1, Akihiro Harada
trans-acting transcription factor 8, targeted mutation 1,
RIKEN cDNA 1700015F17 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
C-type lectin domain family 4, membere, Targeted mutation 1,
collagen, type XX, alpha 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
Janus kinase 3, targeted mutation 1,
sperm acrosome associated 3, targeted mutatiom 1, Research Institute for Microbial Diseases, Osaka University
testis specific gene A13, targeted mutaion 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
PCI domain containing 2, targeted mutation1.2,
myeloblastosis oncogene, targeted mutation 1,
prostaglandin E receptor 2 (subtype EP2), targeted mutation 1
glycerol kinase-like 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
forkhead box J1; targeted mutation 1, Brian P Hackett
cystathionase (cystathionine gamma-lyase); targeted mutation
C-type lectin domain family 1, member a, targeted mutation 1, Yoichiro Iwakura, University of Tokyo
targeted mutation 1, Toho University
serine protease inhibitor, Kunitz type 1, targeted mutation 1,
Basonuclin 2; targeted mutation 3, Center for Animal Resources & Development
Gcnt1, targeted mutation 1
H2, PL allele
H2, NZB allele
Irf1, targeted mutation 1
Irf3, targeted mutation 1
transgene
prostaglandin F receptor, targeted mutation 1, Shu Narumiya
PymrR3, 129 allele
transgene 1
transgene 4
targeted mutation 3, Institute of Molecular Embryology and Genetics
transgene insertion 11, Jun-ichi Miyazaki
heat shock protein 4 like, targeted mutation 1
heat shock protein 4, targeted mutation 1
A, C3H allele
Egfr, waved 2
targeted mutation, knock-in (5Mut)
recombination activating gene 2; targeted mutation 1, RIKEN
targeted mutation 1; Z. Leah Harris
HNF1 homeobox A, targeted mutation 1, Naomi Nakagata, Center for Animal Resources and Development, Kumamoto University
retinol binding protein 4, targeted mutation 1, Naomi Nakagata Center for Animal Resources & Development, Kumamoto University
ringelschwanz
transgene insertion 4, Naohiko Sakai
transgene insertion; Suji Kitajima (Saga University)
transgene insertion, Shoen Kume
sine oculis-related homeobox 4 homolog (Drosophila); targeted mutation 1, Kiyoshi Kawakami
transgene insertion 3, Kiyoshi Kawakami
ATPase, Na+/K+ transporting, alpha 2 polypeptide; targeted mutation 2, Kiyoshi Kawakami
interleukin 1 receptor antagonist, targeted mutation 2, Yoichiro Iwakura University of Tokyo
HNF1 homeobox A, targeted mutation 1, Naomi Nakagata
Free fatty acid receptor 2, targeted mutation 1
targeted mutation 1; Naomi Nakagata
CKLF-like MARVEL transmembrane domain containing 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion, Jun-ichi Miyazaki
transgene insertion 41, Nobuo Sakaguchi
prostaglandin-endoperoxide synthase 2; targeted mutation 2, Hervey Herschman
glycerol phosphate dehydrogenase 2, mitochondrial, targeted mutation 1
VPS52 GARP complex subunit, targeted mutation 1.1
pleiomorphic adenoma gene-like 1, targeted mutation 1
pyruvate kinase, muscle, targeted mutation 1,
high mobility group AT-hook 2, targeted mutation 1, Institute of Molecular Embryology and Genetics.
G protein-coupled receptor 84, targeted mutation 1
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II), endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
melanocortin 1 receptor; recessive yellow
RIKEN cDNA 2900092C05 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
progestin and adipoQ receptor family member VIII, targeted mutation 1
Janus Kinase 3, targeted mutation 1
G protein-coupled receptor 155, targeted mutation 1,
phospholipase C, zeta 1, endonuclease-mediated mutation 4, Research Institute for Microbial Diseases, Osaka University
retinol binding protein 4, plasma, targeted mutation 1,
gametocyte specific factor 2, targeted mutation 1,
TAR DNA binding protein, endonuclease-mediated mutation 1,
calreticulin 3; targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
retinol binding protein 4, plasma, targeted mutation 1, Center for Animal Resources and Development
glycerol phosphate dehydrogenase 2, mitochondrial, endonuclease-mediated mutation 1, Ken-ichi Yamamura
transgene insertion 1, Timothy Stewart
metastasis suppressor 1, targeted mutation 1,
protein disulfide isomerase-like, testis expressed, targeted mutation 1, Research Institute for Microbial Diseases,Osaka University
hematopoietically expressed homeobox; targeted mutation 1, Tamio Noguchi
troponin T2, cardiac, targeted mutation 2, Sachio Morimoto
solute carrier family 18 (vesicular monoamine), member 2,targeted mutation 1a,
sine oculis-related homeobox 1, endonuclease-induced mutation 2
prostaglandin E receptor 3, targeted mutation 1, Shuh Narumiya, Kyoto University
targeted mutation 2, Naomi Nakagata
Adra1b, targeted mutation 1
Pkd1, targeted mutation 1
Tomm34, targeted mutation 2
PymrR2B, 129 allele
transmembrane protein 104; gene trap, Institute of Molecular Embryology and Genetics
Avpr1b, targeted mutation 1
Nidd4, BALB/c allele
Trp53, targeted mutation 1, Shinichi Aizawa
Tlx2, targeted mutation 1
seminal vesicle secretory protein 2, targeted mutation 1,Kenji Miyado, National Center for Child Health and Development
Ptn, targeted mutation 1
Mdk, targeted mutation 1
transgene insertion 4-70
b variant
transgene insertion, Naohiko Sakai, Molecular Disease Branch
EF-hand calcium binding domain 3, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
targeted mutation 1, Jerold Chun
secreted phosphoprotein 1, targeted mutation 1, Brigid L Hogan
HNF1 homeobox B, targeted mutation 1, Naomi Nakagata
pancreas specific transcription factor, 1a; targeted mutation 1, Center for Animal Resources and Development
transgene insertion CX-FM038, Research Institute for Microbial Diseases, Osaka University
izumo sperm-egg fusion 1, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
trasgene insertion
transgene insertion 2, Naohiko Sakai
transgene insertion 3, Hiroko Oshima
chemokine (C-X-C motif) ligand 14; targeted mutation 1, Hiroko Oshima (Kanazawa University)
autophagy-related 5; targeted mutation 1, Minesuke Yokoyama
Pairod-like homeodomein Transcription Factor 2; targeted mutation 1 (lacz), Kunio Kitamura
targeted mutation 1, Akihiko Harada
transgene insertion 266, Keiko Abe
prostaglandin-endoperoxide synthase 2; targeted mutation 1, UCLA
transgene insertion 1, Jun-ichi Miyazaki
high mobility group AT-hook 1, targeted mutation 1, Institute of Molecular Embryology and Genetics.
hypoxanthine guanine phosphoribosyl transferase, targeted mutation 1,
regulator of calcineurin 1, targeted mutation 1,
RAB8B, member RAS oncogene family, targeted mutation 1
neurogenic differentiation 1, targeted mutation 1,
spermatogenesis associated 4, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
kinesin family member 2B, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
cDNA sequence BC051142, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
glucokinase , targeted mutation 1,
family with sequence similarity 217, member A, endonuclease-mediated mutation 2, Research Institute for Microbial Diseases, Osaka University
RIKEN cDNA 1700019N19 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
C1q and tumor necrosis factor related protein 4, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
predicted gene 5617, endonuclease-mediated mutation 2, Research Institute for Microbial Diseases, Osaka University
testis, prostate and placenta expressed, targeted mutation 1a,Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
sperm acrosome associated 3, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
leukocyte receptor cluster (LRC) member 8, targeted mutation 1.2,
propionyl-Coenzyme A carboxylase, alpha polypeptide, targeted mutation 1, Toru Miyazaki
Pmis2, sperm specific protein; targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
zona pellucida 3 receptor, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
Farnesyl diphosphate farnesyl transferase 1, targeted mutation 1, Shun Ishibashi, Jichi Medical University
Gametocyte specific factor 1, targeted mutation 1,
prostaglandin D receptor, targeted mutation 1
solute carrier family 18 (vesicular monoamine), member 2, targeted mutation 1c,
solute carrier family 18 (vesicular monoamine), member 2, targeted mutation 1c,
protein tyrosine phosphatase, receptor type, C; a variant
Protein Kinase D1, targeted mutation 1
thyroid peroxidase, R479C; Hamamatsu University School of Medicine
developing brain homeobox 1, targeted mutation 1,
Ifnar1, targeted mutation 1
targeted mutation 1; Gozoh Tsujimoto
progestin and adipoQ receptor family member VIII, targeted mutation 1, Ikuo Kimura, Kyoto University
eukaryotic translation termination factor 1; gene trap, Institute of Molecular Embryology and Genetics
Dnaja2, targeted mutation 1
D9Mit208, 129 allele
Il2rb, targeted mutation 1, Tak Mak
Nidd6, BALB/c allele
Ifnb, targeted mutation 1
transgene 3
H2, B6 allele
Cdkn1b, targeted mutation 1
C6st, targeted mutation 1
Clcnk, targeted mutation 1
targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
mouse Secreted phosphoprotein 1; transgenic
targeted mutation 1, Jun-ichi Miyazaki
gene trap Ayu21-49, Institute of molecular embryology and genetics
prostaglandin D receptor, targeted mutation 1, Shu Narumiya
seminal vesicle secretory protein 2, targeted mutation 1
ankyrin and armadillo repeat containing, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transgene insertion 11, Yoshiaki Nakajima
hyaluronan and proteoglycan link protein 4; targeted mutation 1, Toshitaka Oohashi
growth hormone, targeted mutation 1
seminal vesicle secretory protein 2; targeted mutation 2, Kenji Miyado
EH domain binding protein 1, targeted mutation 1,
transgene insertion, Nobuaki Tamamaki, Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University
glucokinase, targeted mutation 1, Naomi Nakagata
transgene insertion 39, Jun-ichi Miyazaki
targeted mutation 1, Yumiko Saga, National Institute of Genetics
Oligodendrocyte transcription factor 2; targeted mutation 1, Hirohide Takebayashi
DnaJ (Hsp40) homolog, subfamily A, member 4; targeted mutation 1, Naomi Nakagata
transgene insertion 064 Hamamatsu University School of Medicine
transgene insertion 046 Hamamatsu University School of Medicine
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog, Targeted mutation 1
transgene insertion, Naomi Nakagata, Center for Animal Resources & Development
zinc finger protein 296, targeted mutation 1,Jun-ichi Miyazaki, Division of Stem Cell Regulation Research, Osaka University Medical School
serine protease inhibitor Kazal type 1, targeted mutation 1, Naomi Nakagata, Center for Animal Resources and Development
transgene insertion 1, Research Institute for Microbial Diseases, Osaka University
t-complex-associated testis expressed 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
transketolase-like 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
RIKEN cDNA 4933417A18 gene, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
fumarylacetoacetate hydrolase, targeted mutation 1
paired box 6, targeted mutation 1,
coiled coil domain containing 178, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
ubiquitin-conjugating enzyme E2U (putative), endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13, targeted mutation 1
developmental pluripotency associated 1, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
DnaJ heat shock protein family (Hsp40) member B13, endonuclease-mediated mutation 1, Research Institute for Microbial Diseases, Osaka University
minichromosome maintenance complex component 3 associated protein; targeted mutation 1, Nobuo Sakaguchi
zinc finger, CCHC domain containing 13 , targeted mutation 1, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
heat shock protein 4 like, targeted mutation 1,
chemokine (C-C motif) ligand 8 , targeted mutation 1,
prostate and testis expressed 4, targeted mutation 1, Research Institute for Microbial Diseases, Osaka University
myeloblastosis oncogene, targeted mutaiton 2
lymphocyte antigen 6 complex, locus K, targeted mutation 1, Research Institute for Microbial Diseases,Osaka University
lysozyme-like 4, targeted mutation 1a, Animal Resource Center for Infectious Diseases Research Institute for Microbial Diseases Osaka University
cystathionine beta-synthase, targeted mutation 1
prostaglandin E receptor 2, targeted mutation 1, Shuh Narumiya, Kyoto University